News & Updates

Show Multimedia Only

$Early initiation of anti-osteoporosis medication reduces fracture events$

Early initiation of anti-osteoporosis medication reduces fracture events

22 May 2022

For patients on glucocorticoid therapy, a delay in anti-osteoporosis treatment initiation may lead to increased fracture events, while early treatment helps to prevent them, a study has found.

22 May 2022

Which canagliflozin dose is best for T2DM patients with hypertension?

22 May 2022

A recent meta-analysis offers new proof of different canagliflozin doses for hypertension management in patients with type 2 diabetes mellitus (T2DM) complicated by hypertension. However, low-density lipoprotein cholesterol (LDL-C) and the risk of urinary tract infection must be observed.

22 May 2022

Early evolocumab helps reduce LDL-C levels, prevent recurrent ischaemic cardiovascular events

21 May 2022

In acute coronary syndrome (ACS) patients who have undergone percutaneous coronary intervention (PCI), early treatment with evolocumab as an addition to statin can lower low-density lipoprotein cholesterol (LDL-C) levels as well as reduce the incidence of recurrent ischemic cardiovascular events, while having satisfactory tolerability and safety, according to a study.

21 May 2022

Fezolinetant reduces hot flashes in menopausal women

21 May 2022 by

Treatment with fezolinetant significantly reduced the frequency and severity of vasomotor symptoms (VMS), particularly hot flashes, in women during their menopausal phase, according to the SKYLIGHT 1* trial presented at ACOG 2022.

21 May 2022

Male sex, obesity among risk factors for severe COVID-19 in children

20 May 2022 by

A large study by the US National COVID Cohort Collaborative (N3C) has identified factors associated with the risk of severe disease among children with SARS-CoV-2 infection as well as factors tied to an increased risk of multisystem inflammatory syndrome in children (MIS-C) as compared to acute COVID-19.

20 May 2022

Antidepressant exposure in pregnancy not a risk factor for neonatal seizures, epilepsy

20 May 2022 by

In pregnant women, the use of serotonergic antidepressants does not appear to put babies at risk of developing seizures or epilepsy, as reported in a study.

20 May 2022

Infliximab does not contribute to long-term weight gain in IBD patients

20 May 2022 by

Treatment with infliximab does not lead to a general long-term weight gain in patients with inflammatory bowel disease (IBD), claims a study.

20 May 2022

Investigational drug gains upper hand over placebo in reducing CDI recurrence rates

20 May 2022 by

SER-109, an investigational oral microbiome therapeutic, achieves superiority over placebo in reducing recurrent Clostridioides difficile infection (CDI) rates, according to updated findings from the phase III ECOSPOR-III trial.

20 May 2022

Stroke while on anticoagulant therapy predicts recurrence, bleeding risks

20 May 2022

Patients who have had a stroke despite being on nonvitamin K antagonist oral anticoagulant therapy are likely to experience a recurrent ischaemic stroke episode and bleeding, according to data from the RENO-EXTEND Study.

20 May 2022

Once-daily, low-dose elagolix reduces HMB in premenopausal women with uterine fibroids

20 May 2022 by

Once-daily (QD) administration of low-dose elagolix 150 mg led to significantly reduced heavy menstrual bleeding (HMB) in premenopausal women with uterine fibroids, according to a study presented at ACOG 2022.

20 May 2022

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Early initiation of anti-osteoporosis medication reduces fracture events

Which canagliflozin dose is best for T2DM patients with hypertension?

Early evolocumab helps reduce LDL-C levels, prevent recurrent ischaemic cardiovascular events

Fezolinetant reduces hot flashes in menopausal women

Male sex, obesity among risk factors for severe COVID-19 in children

Antidepressant exposure in pregnancy not a risk factor for neonatal seizures, epilepsy

Infliximab does not contribute to long-term weight gain in IBD patients

Investigational drug gains upper hand over placebo in reducing CDI recurrence rates

Stroke while on anticoagulant therapy predicts recurrence, bleeding risks

Once-daily, low-dose elagolix reduces HMB in premenopausal women with uterine fibroids